888325-29-9

Usage

Uses

Used in Food and Beverage Industry:
4-hydroxy-3,3-dimethylcyclohexanone is used as a flavoring agent for its distinct minty aroma, enhancing the taste and appeal of various food and beverage products.
Used in Medicinal Applications:
4-hydroxy-3,3-dimethylcyclohexanone serves as an insect repellent, capitalizing on its natural properties to deter insects and provide a non-toxic alternative to chemical repellents.
Used in Pharmaceutical Industry:
4-hydroxy-3,3-dimethylcyclohexanone is used for its potential anti-inflammatory and analgesic effects, offering a natural approach to managing pain and inflammation.
Used in Cancer Therapy Research:
4-hydroxy-3,3-dimethylcyclohexanone is explored for its potential use in cancer therapy, with ongoing studies investigating its effects on cancer cells and possible synergistic benefits when combined with conventional treatments.
Approved by Regulatory Bodies:
4-hydroxy-3,3-dimethylcyclohexanone is considered safe for consumption and is approved for use in food products by the Food and Drug Administration (FDA), ensuring its widespread application in the food and beverage industry.

Upstream product

• 134409-06-6 4,4-ethylenedioxy-2,2-dimethylcyclohexanone 
• 131206-74-1 (+/-)-2,2-dimethyl-4,4-ethylendioxy-1-cyclohexanol 

Downstream Products

• 888325-30-2 (+/-)-5-((2-methoxyethoxy)methoxy)-2-hydroxy-4,4-dimethylcyclohex-1-enecarboxylic acid methyl ester 
• 888325-28-8 (+/-)-3,3-dimethyl-4-[(2-methoxyethoxy)methoxy]-1-cyclohexanone 

Relevant academic research and scientific papers

Discovery of the Selective Protein Kinase C-θ Kinase Inhibitor, CC-90005

The PKC-θ isoform of protein kinase C is selectively expressed in T lymphocytes and plays an important role in the T cell antigen receptor (TCR)-triggered activation of mature T cells, T cell proliferation, and the subsequent release of cytokines such as

PYRAZOLE DERIVATIVES AS BROMODOMAIN INHIBITORS

The present invention is directed to pyrazole derivatives, pharmaceutical compositions comprising the compounds and the use of the compounds or the compositions in the treatment of various diseases

SUBSTITUTED DIAMINOPYRIMIDYL COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH

Provided herein are diaminopyrimidyl Compounds having the following structures: wherein X, L, R1, and R2 are as defined herein, compositions comprising an effective amount of a Diaminopyrimidyl Compound, and methods for treating or preventing PKC-theta-mediated disorders, or a condition treatable or preventable by inhibition of a kinase, for example, PKC-theta.

Discovery of huperzine A-tacrine hybrids as potent inhibitors of human cholinesterases targeting their midgorge recognition sites

We describe herein the development of novel huperzine A-tacrine hybrids characterized by 3-methylbicyclo-[3.3.1]non-3-ene scaffolds. These compounds were specifically designed to establish tight interactions, through different binding modes, with the midg